Multicentric CastlemanÕs Disease

Active Research Protocols

  1. 03-DK-0226 – Pulse Dexamethasone Over 48 Weeks for Podocyte Disease
  2. 04-C-0275 – Targeted Oncolytic Virotherapy and Natural History Study of KSHV-Associated Multicentric Castleman's Disease with Laboratory and Clinical Correlates of Disease Activity
  3. 05-DK-0015 – Retinoids for Podocyte Disease
  4. 11-C-0220 – Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS) Incorporating Pilot Evaluation of KSHV Targeted Therapies
  5. 11-C-0233 – Pilot Study of Tocilizumab in Patients with Symptomatic Kaposi Sarcoma Herpesvirus (KSHV) - Associated Multicentric Castleman Disease
  6. 11-DK-0023 – The Nephrotic Syndrome Study Network (NEPTUNE)
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014